Affiliations: Central Research Laboratories, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan
Correspondence:
[*]
Correspondence and reprint requests to: Toshio Kamiya, Central Research Laboratories, The Green Cross Corporation, 2-25-1 Shodai-Ohtani, Hirakata, Osaka 573, Japan.
Abstract: Human immunoglobulin E (IgE) contains a potential recognition sequence for thrombin protease cleavage at N-terminal end of Cε3 domain responsible for binding to α chain of high affinity Fc receptor for IgE (FcεRICα, but it remains unknown for the enzyme susceptibility. The human Fc fragments of IgE (IgE-Fc), consisting of Cε2'(Ala329)-Cε3-Cε4 chains (Fc') and ofCε2'(Thr315-Ala329)-Cε3-Cε4 chains (F(c')2), were expressed in the mammalian COS and Chinese hamster ovary (CHO) cells by placing the /gE-Fc cDNA under the control of the cytomegalovirus (CMV) promoter. Under nonreducing condition F(c')2 was not cleaved by thrombin protease as well as native IgE. Neither treatment of F(c')2 with final 0.1% 2-mercaptoethanol at boiling point for 5 min, with a sulfhydryl-reactive biotin derivative, by which monomers in COS-derived F(c'h)2 preparations were biotinylated at Cys328, nor with neuraminidase, affected the accessibility to the enzyme. These results suggested that F(c'h)2, either dimeric or monomeric, had compact conformations.
